new approaches to decreasing preterm births with Makena (hydroxyprogesterone) and terbutaline

Please see the November 2011 FDA statement concerning Makena.

You'll see new approaches to decreasing preterm births with Makena (hydroxyprogesterone) and terbutaline.

One in eight babies is born prematurely in the United States.

Makena (mah-KEE-na) is the first drug APPROVED for reducing the risk of preterm birth...but it's not really new.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote